- Home
- ITIC vs TMCI Comparison
ITIC vs TMCI Comparison
Compare ITIC & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITIC
- TMCI
- Stock Information
- Founded
- ITIC 1972
- TMCI 2014
- Country
- ITIC United States
- TMCI United States
- Employees
- ITIC N/A
- TMCI N/A
- Industry
- ITIC Specialty Insurers
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ITIC Finance
- TMCI Health Care
- Exchange
- ITIC Nasdaq
- TMCI Nasdaq
- Market Cap
- ITIC 440.1M
- TMCI 460.5M
- IPO Year
- ITIC N/A
- TMCI 2021
- Fundamental
- Price
- ITIC $195.87
- TMCI $5.81
- Analyst Decision
- ITIC
- TMCI Hold
- Analyst Count
- ITIC 0
- TMCI 6
- Target Price
- ITIC N/A
- TMCI $9.18
- AVG Volume (30 Days)
- ITIC 90.6K
- TMCI 507.1K
- Earning Date
- ITIC 08-05-2025
- TMCI 05-08-2025
- Dividend Yield
- ITIC 0.94%
- TMCI N/A
- EPS Growth
- ITIC 18.56
- TMCI N/A
- EPS
- ITIC 15.69
- TMCI N/A
- Revenue
- ITIC $261,197,999.00
- TMCI $210,819,000.00
- Revenue This Year
- ITIC N/A
- TMCI $10.61
- Revenue Next Year
- ITIC N/A
- TMCI $10.36
- P/E Ratio
- ITIC $12.37
- TMCI N/A
- Revenue Growth
- ITIC 15.27
- TMCI 7.54
- 52 Week Low
- ITIC $168.74
- TMCI $4.54
- 52 Week High
- ITIC $290.40
- TMCI $10.79
- Technical
- Relative Strength Index (RSI)
- ITIC 29.02
- TMCI 33.96
- Support Level
- ITIC $190.20
- TMCI $5.63
- Resistance Level
- ITIC $235.99
- TMCI $6.01
- Average True Range (ATR)
- ITIC 8.84
- TMCI 0.27
- MACD
- ITIC -5.20
- TMCI -0.02
- Stochastic Oscillator
- ITIC 9.11
- TMCI 15.32
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.